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A series of cobalt, nickel, copper, and zinc complexes of bidentate Schiﬀ bases derived from the condensation reaction of 4-amino-
5-mercapto-3-methyl/ethyl-1,2,4-triazole with 2,4-dichlorobenzaldehyde were synthesized and tested as antimicrobial agents. The
synthesized Schiﬀ bases and their metal complexes were characterized with the aid of elemental analyses, magnetic moment
measurements, spectroscopic and thermogravimetric techniques. The presence of coordinated water in metal complexes was
supported by infrared and thermal gravimetric studies. A square planar geometry was suggested for Cu(II) and octahedral
geometry proposed for Co(II), Ni(II), and Zn(II) complexes. The Schiﬀ bases and their metal complexes have been screened for
antibacterial (Pseudomonas aeruginosa, Bacillus subtilis) and antifungal activities (Aspergillusniger, A.ﬂavus). The metal complexes
exhibited signiﬁcantly enhanced antibacterial and antifungal activity as compared to their simple Schiﬀ bases.
1.Introduction
Of late due to the constant emergence of antibiotics resis-
tance to clinically used compounds, it is the need of the hour
to develop novel antibiotics classes, which eventually would
target the lipoid layer of the organisms and other aspects
of pathogens’ life cycle. Metal complexes may be subjected
for the design and synthesis of such possibilities having such
biological activities [1–3]. The chemistry of Schiﬀ bases and
their structural analogues has occupied a place of consider-
ableimportance[4]astheyeasilyformstablecomplexeswith
mosttransitionmetalions[5,6]andwell-establishedbiolog-
ical properties. 1,2,4-triazoles nucleus and their derivatives
emerge rapidly with the advances of modern heterocyclic
chemistry, promising a variety of medical applications such
as antibacterial, antifungal, anticancer, antitumor, anticon-
vulsant, anti-inﬂammatory, and analgesic properties [7–12].
Schiﬀ bases of 1,2,4-triazoles ﬁnd diverse applications and
extensive biological activity. The incorporation of the 1,2,4-
triazole unit into Schiﬀ base macrocycles is of considerable
current interest as complexes of 1,2,4-triazoles are being
developed for potential use in applications such as magnetic
materials and photo chemically driven molecular devices
[13]. Schiﬀ bases derived from 3-substituted-4-amino-5-
mercapto-1,2,4-triazoles show analgesic, antimicrobial, anti-
inﬂammatory, and antidepressant activities [14].
The aim of the present study was to modify the bio-
activities of 1,2,4-triazole Schiﬀ bases and gain the relative
derivatives with better curing eﬀect, optimization of hydro-
philic/lipophilic character, and improve the bioavailability
by coordinating them with transition metal ions. During
the course of this work, a series of cobalt, nickel, cop-
per, and zinc complexes of bidentate Schiﬀ bases derived
from the condensation reaction of 4-amino-5-mercapto-3-
methyl/ethyl-1, 2, 4-triazole with 2, 4-dichlorobenzaldehyde
have been synthesized. The synthesized Schiﬀ bases and their
metalcomplexeswerecharacterizedwiththeaidofelemental
analyses, magnetic moment measurements, spectroscopic,
and thermogravimetric techniques. The Schiﬀ bases and
their metal complexes have been screened for antibacterial
(Pseudomonas aeruginosa, Bacillus subtilis) and antifungal
activities (Aspergillus niger, A. ﬂavus).2 Bioinorganic Chemistry and Applications
2. Experimental
2.1. Materials and Methods. All the chemicals used in the
present investigation were of Analytical grade and used
without further puriﬁcation. The metal contents were deter-
mined using standard gravimetric methods; cobalt was
estimated as cobalt pyridine thiocyanate, nickel as nickel
dimethylglyoximate,copperascuprousthiocyanate,andzinc
as zinc ammonium phosphate [15].
The Perﬁt electrical melting point apparatus is used to
record melting points of the synthesized complexes and are
uncorrected.Carbon,hydrogen,andnitrogenwereestimated
using Perkin-Elmer 2400 Elemental Analyzer at Punjab
University, Chandigarh. Electronic spectra of metal com-
plexes were recorded in DMF on a Systronics 2203 double-
beam spectrophotometer in the region 1100–200nm. IR
spectra were recorded on a MB-3000 ABB spectrometer
in KBr/Nujol mulls in the range 4000–250cm−1.P r o t o n
NMR spectra were recorded in DMSO-d6 on a Bruker
ACF 300 spectrometer at 300 MHz using “tetramethyl
silane” as the internal standard. Magnetic moments were
measured at Institute Instrumentation Centre, IIT Roorkee
on vibrating sample magnetometer (Model 155). The Perkin
Elmer (Pyris Diamond) instrument was used to carry out
thermal analysis of metal complexes in atmospheric air at
the heating rate of 10◦CMin −1 using a reference to alumina
powder. The EPR spectrum of the copper(II) complex was
recorded at SAIF, IIT, Bombay, using VARIAN E-112 X-
band EPR spectrometer with cylindrical quartz sample tube
operating at microwave frequency 9.5GHz. Field calibration
was checked using tetracyanoethylene (TCNE) free radical
for which g = 2.0027 at room temperature.
2.2. Syntheses. 4-Amino-5-mercapto-3-methyl-1,2,4-tria-
zole (ammt) and 4-amino-3-ethyl-5-mercapto-1,2,4-triazole
(aemt) were prepared by reported literature method [16].
2.2.1. 4-[(2,4-Dichloro-benzylidene)-amino]-5-mercapto-3-
methyl-1,2,4-triazole (HL1). An ethanolic solution (40mL)
of ammt (1.08g, 8.33mmol) was treated with 2,4-dichlo-
robenzaldehyde (1.45g, 8.33mmol). The reaction mixture
was reﬂuxed for 3h, and then the clear solution was allowed
to cool to room temperature. The solid material formed
was removed by ﬁltration, washed with cold ethanol, and
recrystallized from ethanol and dried (Figure 1).
m.p. 249–252◦C, (found: C, 41.78; H, 2.78; N, 19.46%.
Calcd. For C10H8Cl2N4S: C, 41.82; H, 2.81; N, 19.51%); MS:
m/z (M + 1) 286.9, (M − 1) 284.9.
2.2.2. 4-[(2,4-Dichloro-benzylidene)-amino]-3-ethyl-5-mer-
capto-1,2,4-triazole (HL2). An ethanolic solution of aemt
(1.41g, 9.79mmol) was added with stirring to an ethanolic
solution of 5-nitro-furfuraldehyde (1.71g, 9.79mmol) and
reﬂuxed for 3h, and the product was ﬁltered oﬀ, washed
with ice cold ethanol, and a light yellow crystalline product
was obtained after recrystallization from ethanol (Figure 1).
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Figure 1: Scheme for the synthesis of Schiﬀ bases.
m.p. 236–239◦C, (found: C, 43.22; H, 3.28; N, 18.43%.
calcd. For C11H10Cl2N4S: C, 43.86; H, 3.35; N, 18.60%); MS:
m/z (M + 1) 300.9, (M − 1) 298.9.
2.2.3. Syntheses of Metal Complexes of [HL1]( 1 : 1 ) .The
hot ethanolic solutions of the HL1 (0.22g, 0.76mmol) were
slowly added to the aqueous ethanolic solutions of acetates
of Co(II) (0.19g, 0.76mmol), Ni(II) (0.19g, 0.76mmol),
Cu(II) (0.15g, 0.76mmol), and Zn(II) (0.16g, 0.76mmol),
which resulted in the immediate precipitation of metal
derivatives. The products formed were ﬁltered and puriﬁed
by washing thoroughly with warm water, with aqueous
ethanol to remove unreacted metal acetates or ligands, and
ﬁnally with acetone and dried.
Co(L1)OAc·3H2O: (found: C, 31.28; H, 3.38; N, 12.10;
Co,12.78%calcd.ForC12H16Cl2CoN4O5S:C,31.46;H,3.52;
N, 12.23; Co, 12.86%).
Ni(L1)OAc·3H2O: (found: C, 31.38; H, 3.43; N, 12.16;
Ni, 12.72% calcd. For C12H16Cl2N4NiO5S: C, 31.47; H, 3.52;
N, 12.23; Ni, 12.82%).
Cu(L1)OAc·H2O:(found:C,39.44;H,2.68;N,16.88;Cu,
9.54% calcd. For C12H12Cl2CuN4O3S: C, 39.80; H, 2.73; N,
16.88; Cu, 9.57%).
Zn(L1)OAc·3H2O: (found: C, 30.99; H, 3.41; N, 11.96;
Zn,14.00%calcd.ForC12H16Cl2N4O5SZn:C,31.02;H,3.47;
N, 12.06; Zn, 14.07%).
2.2.4. Syntheses of Metal Complexes of [HL1]( 1 : 2 ) .The
aqueous ethanolic solutions of acetates of Co(II) (0.17g,
0.69mmol), Ni(II) (0.17g, 0.69mmol), Cu(II) (0.14g,
0.69mmol) and Zn(II) (0.15g, 0.69mmol) were treated with
the hot ethanolic solutions of the HL1 (0.40g, 1.39mmol).
The products formed were ﬁltered and puriﬁed by washing
thoroughly with warm water, with aqueous ethanol to
remove unreacted metal acetates or ligands and ﬁnally with
acetone and dried.Bioinorganic Chemistry and Applications 3
Co(L1)2·2H2O: (found: C, 35.88; H, 2.67; N, 16.73; Co,
8.80% calcd. For C20H18Cl4CoN8O2S2: C, 36.00; H, 2.72; N,
16.79; Co, 8.83%).
Ni(L1)2·2H2O: (found: C, 36.00; H, 2.62; N, 16.55; Ni,
8.76% calcd. For C20H18Cl4N8NiO2S2: C, 36.01; H, 2.72; N,
16.80; Ni, 8.80%).
Cu(L1)2: (found: C, 33.65; H, 2.77; N, 13.61; Cu, 14.77%
calcd. For C20H14Cl4CuN8S2: C, 33.77; H, 2.83; N, 13.63; Cu,
14.89%).
Zn(L1)2·2H2O: (found: C, 35.60; H, 2.61; N, 16.58; Zn,
9.68% calcd. For C20H18Cl4N8O2S2Zn: C, 35.65; H, 2.69; N,
16.63; Zn, 9.71%).
2.2.5. Syntheses of Metal Complexes of [HL2]( 1:1 ) . The hot
ethanolic solutions of the HL2 (0.31g, 1mmol) were added
to the aqueous ethanolic solutions of acetates of Co(II)
(0.25g, 1mmol), Ni(II) (0.25g, 1mmol), Cu(II) (0.20g,
1mmol) and Zn(II) (0.22g, 1mmol), which resulted in the
immediate precipitation of metal derivatives. The products
formed were ﬁltered and puriﬁed by washing thoroughly
with warm water, with aqueous ethanol to remove unreacted
metal acetates or ligands and ﬁnally with acetone and dried.
Co(L2)OAc·3H2O: (found: C, 33.00; H, 3.84; N, 11.77;
Co,12.43%calcd.ForC13H18Cl2CoN4O5S:C,33.07;H,3.84;
N, 11.86; Co, 12.48%).
Ni(L2)OAc·3H2O: (found: C, 32.97; H, 3.81; N, 11.81;
Ni, 12.44% calcd. For C13H18Cl2N4NiO5S: C, 33.08; H, 3.84;
N, 11.87; Ni, 12.44%).
Cu(L2)OAc·H2O:(found:C,35.42;H,3.18;N,12.20;Cu,
14.48% calcd. For C13H14Cl2CuN4O3S: C, 35.42; H, 3.20; N,
12.71; Cu, 14.42%).
Zn(L2)OAc·3H2O: (found: C, 32.60; H, 3.78; N, 15.73;
Zn, 9.31% calcd. For C13H18Cl2N4O5SZn: C, 32.62; H, 3.79;
N, 15.97; Zn, 9.32%).
2.2.6. Syntheses of Metal Complexes of [HL2]( 1 : 2 ) .The
aqueous ethanolic solutions of acetates of Co(II) (0.20g,
0.83mmol), Ni(II) (0.20g, 0.83mmol), Cu(II) (0.16g,
0.83mmol), and Zn(II) (0.18g, 0.83mmol) were treated
with the hot ethanolic solutions of the HL2 (0.50g,
1.6mmol). The products formed were ﬁltered and puriﬁed
by washing thoroughly with warm water, with aqueous
ethanol to remove unreacted metal acetates or ligands, and
ﬁnally with acetone and dried.
Co(L2)2·2H2O: (found: C, 37.77; H, 3.18; N, 16.13; Co,
8.48% calcd. For C22H22Cl4CoN8O2S2: C, 38.00; H, 3.19; N,
16.12; Co, 8.48%).
Ni(L2)2·2H2O: (found: C, 38.80; H, 3.15; N, 16.14; Ni,
8.45% calcd. For C22H22Cl4N8NiO2S2: C, 38.81; H, 3.19; N,
16.12; Ni, 8.44%).
Cu(L2)2: (found: C, 39.21; H, 2.88; N, 16.83; Cu, 9.55%
calcd. For C22H18Cl4CuN8S2: C, 39.80; H, 2.73; N, 16.88; Cu,
9.57%).
Zn(L2)2·2H2O: (found: C, 37.66; H, 3.15; N, 15.95; Zn,
9.32% calcd. For C22H22Cl4N8O2S2Zn: C, 37.65; H, 3.16; N,
15.97; Zn, 9.31%).
2.3. Antimicrobial Assay
2.3.1. Test Microorganisms. Four microbial strains were
selected on the basis of their clinical importance in causing
diseases in humans. Two bacteria (Staphylococcus aureus
MTCC 96 and Bacillus subtilis MTCC 121) and two fungi,
Aspergillus niger and A. ﬂavus, the ear pathogens isolated
from the patients of Kurukshetra [17], were used in the
present study for evaluation of antimicrobial activity of
the synthesized compounds. All the bacterial cultures were
procured from Microbial Type Culture Collection (MTCC),
IMTECH, Chandigarh. The bacteria were subcultured on
Nutrient agar, whereas fungi on Sabouraud’s dextrose agar.
2.3.2. Antibacterial Activity. The antibacterial activity of all
the synthesized complexes was evaluated by using agar well-
diﬀusion method. All the microbial cultures were adjusted
to 0.5 McFarland standard, which is visually comparable to
a microbial suspension of approximately 1.5 × 108 cfu/mL.
20mL of Mueller Hinton agar medium was poured into each
Petri plate and plates were swabbed with 100μL inocula of
the test microorganisms and kept for 15min for adsorption.
Using sterile cork borer of 8mm diameter, wells were
bored into the seeded agar plates, and these were loaded
with a 100μL volume with concentration of 4.0mg/mL of
each compound reconstituted in the dimethylsulphoxide
(DMSO). All the plates were incubated at 37◦C for 24hrs.
Antibacterial activity of each compound was evaluated
by measuring the zone of growth inhibition against the
test organisms with zone reader (HiAntibiotic zone scale).
DMSO was used as a negative control whereas Ciproﬂoxacin
was used as positive control. This procedure was performed
in three replicate plates for each organism [18, 19].
2.3.3. Minimum Inhibitory Concentration (MIC) Determina-
tion. MIC of all the compounds against bacterial strains was
tested through a modiﬁed agar well-diﬀusion method [20].
In this method, a twofold serial dilution of each compound
was prepared by ﬁrst reconstituting the compound in DMSO
followed by dilution in sterile distilled water to achieve
a decreasing concentration range of 256 to 0.5μg/mL. A
100μL volume of each dilution was introduced into wells
(in triplicate) in the agar plates already seeded with 100μL
of standardized inoculums (106 cfu/mL) of the test microbial
strain. All test plates were incubated aerobically at 37◦Cf o r
24hrs and observed for the inhibition zones. MIC, taken
as the lowest concentration of the chemical compound that
completely inhibited the growth of the microbe, showed by a
clear zone of inhibition, was recorded for each test organism.
Ciproﬂoxacin was used as positive control.
2.3.4. Antifungal Activity. The antifungal activity of Schiﬀ
bases and their metal complexes was evaluated by poison
food technique [21] .T h em o l d sw e r eg r o w no nS a b o u r a u d ’ s
dextrose agar (SDA) at 25◦Cf o r7d a y sa n du s e da s
inocula. The 15mL of molten SDA (45◦C) was poisoned by
the addition of 100μL volume of each compound having
concentration of 4.0mg/mL reconstituted in DMSO, poured4 Bioinorganic Chemistry and Applications
into a sterile Petri plate, and allowed it to solidify at
room temperature. The solidiﬁed poisoned agar plates were
inoculated at the center with fungal plugs (8mm diameter)
obtained from the colony margins and incubated at 25◦C
for 7 days. DMSO was used as the negative control whereas
ﬂuconazolewasusedasthepositivecontrol.Theexperiments
were performed in triplicates. Diameter of fungal colonies
was measured and expressed as percent mycelial inhibition.
Percent inhibition of mycelial growth = (dc − dt)/dc ×
100.
dc: average diameter of fungal colony in negative control
sets.
dt: average diameter fungal colony in experimental sets.
3. Results andDiscussion
The Schiﬀ bases (Figure 1) were soluble in ethanol and
methanol. All the metal complexes are colored, nonhygro-
scopic solids stable in air, insoluble in water and many
common organic solvents but soluble in DMF and DMSO,
decomposed at higher temperature. The elemental analysis
supports the formation of 1:1 and 1:2 metal complexes
of HL1-2 with Co(II), Ni(II), Cu(II), and Zn(II) metal ions.
The molar conductance values of the complexes (measured
in 10−3 MDMF) are in the range 1.5–3.6ohm−1 cm2 mol−1
indicating the nonelectrolytic nature [22]. The purity of
ligands and their metal complexes has been checked by
TLC.
3.1.IRSpectra. TheIRspectraldataoftheSchiﬀbaseligands
and their complexes are listed in Table 1. The IR spectra
of the complexes have been compared with those of the
free ligand in order to determine the coordination sites that
may get involved in chelation. By comparing, it was found
that azomethine group frequency ν(N=CH) is present in the
free ligands at 1595–1597cm−1. This band is shifted to the
lower frequency (22–24) by 5–15cm−1 in the spectra of the
complexes, indicating coordination of azomethine nitrogen
towards the metal ion (M–N).
A new band at 485–514cm−1 due to ν(M–N) is further
conﬁrmedthecoordinationofmetaltoazomethinenitrogen.
The Schiﬀ bases exhibit a weak broad band around ∼
2700cm−1 due to ν(S–H) vibrations [23, 24]. This band
disappeared in the spectra of the metal complexes indicating
deprotonation and complexation through sulphur. In the
spectraofmetalcomplexes,bandsappearedat733–771cm−1
and 334–352cm−1 were assigned to ν(C–S) and ν(M–S),
respectively [22, 25]. In the spectra of metal complexes,
a broad band in the region 3200–3490cm−1 indicated
the presence of coordinated water molecules. A strong
band in the region 1738–1750cm−1 has been assigned to
ν(OOCCH3) in 1:1 metal complexes.
3.2. 1HN M RS p e c t r a .The 1HN M Rs p e c t r ah a v eb e e n
recorded for Schiﬀ bases and Zn(II) complexes (Table 2).
The NMR spectra of metal complexes indicated a shift
of electron density from the ligand to metal. The ligands
[HL1-2] showed characteristic azomethine proton singlet at δ
10.40 and 10.55ppm, respectively. The characteristic signal,
due to azomethine proton deshielded in the spectra of metal
complexes, suggests coordination of metal ion to azomethine
nitrogen atom [23, 25, 26]. In addition to this, the signal at
δ 11.10–11.09ppm is ascribed to SH proton. Disappearance
of SH protons signal in the spectra of metal complexes
supported the deprotonation of thiol group and chelation
with metal (M–S). The aromatic protons of Schiﬀ bases
appeared as a double of doublet and two doublets at δ 7.35,
7.52 and 8.08ppm, respectively. These aromatic protons
signals show a slight downﬁeld shift upon coordination.
In the spectra of 1:1 Zn complexes singlet at δ 2.29 and
2.32ppm are due to methyl group of acetate ion.
3.3. Magnetic Measurements and Electronic Spectra. The
magnetic moment measurements and electronic spectra
provided good information regarding the arrangements
of the ligands around the metal ions (Table 3). The 1:1
and 1:2 Co(II) complexes show magnetic moment (μeﬀ.)
4.83–4.95BM, well within the expected range of octahedral
complex (4.3–5.2BM) [24, 27]. Co(II) complexes exhibit
two absorption bands in the region 10885–10935cm−1 (ν1)
and 20010–20998cm−1 (ν3), which are assigned to 4T1g(F)
→ 4T2g(F) (ν1); 4T1g(F) → 4T1g(P) (ν3) transitions [23–
25, 27]. These are the characteristic bands of high spin
octahedral Co(II) complexes; ν2 is not observed, but it can
be calculated [28, 29] by using relation ν2 = ν1 + 10Dq,
which is very close to (ν3) transition. The ligand ﬁeld
parameters (Dq, B, β, β%) have also been calculated for
Co(II) complexes by using Band-ﬁtting equation [30]. The
crystal ﬁeld stabilizing energy (Dq) value was found to be
∼1200cm−1. These values are well within the range reported
for the octahedral complexes [30]. The Racah parameter
(B) is found to be 683–755cm−1 (<971cm−1), suggesting
an overlapping of ligand metal orbital’s. The nephelauxetic
ratio (β) for the 1:1 and 1:2 cobalt complexes is less
than one suggesting partial covalency in the metal ligand
bond.
The nickel complexes show magnetic moment in the
range 3.43–3.47BM, which corresponds to octahedral envi-
ronment around the central metal ion. Nickel(II) complexes
generally show three absorption bands in octahedral envi-
ronment corresponding to 3A2g(F) → 3T2g(F) (ν1), 3A2g(F)
→ 3T1g(F) (ν2)a n d3A2g(F) → 3T1g(P) (ν3) transitions [28].
The1:1and1:2Ni(II)complexesofHL 1−2 Schiﬀ bases also
show above three transitions in the region 9999–10123cm−1
(ν1), 16380–17320cm−1 (ν2), and 24885–24993cm−1 (ν3),
suggesting distorted octahedral geometry for the complexes.
The ligand ﬁeld parameters (Dq, B, β, β%) have also
been calculated for Ni(II) complexes by using Band-ﬁtting
equation[30].Theseparametersindicatesigniﬁcantcovalent
character of the metal ligand bonds.
The Cu(II) complex has magnetic moment value 1.92–
2.11BM, which fall in the normal range (1.7–2.2BM). The
electronic spectra of Cu(II) complexes showed broad band
around 18550cm−1, which is assigned to 2B1g → 2A1g
(ν1) transition. It is a characteristic band of square planar
geometry around the Cu(II) [31].Bioinorganic Chemistry and Applications 5
Table 1: IR spectral data of the ligands and their metal complexes (cm−1).
Compound ν(N=CH) ν(C–S) ν(S–H) ν(OOCCH3) ν(H2O/OH) ν(M–S) ν(M–N)
HL1 1595 — 2732 — — — —
Co(L1)(OAc)·3H2O 1585 741 — 1744 3426 338 498
Co(L1)2·2H2O 1585 743 — — 3488 334 494
Ni(L1)(OAc)·3H2O 1587 749 — 1742 3471 342 510
Ni(L1)2·2H2O 1588 733 — — 3394 339 514
Cu(L1)(OAc)·H2O 1590 748 — 1744 3310 345 513
Cu(L1)2 1589 750 — — — 348 491
Zn(L1)(OAc)·3H2O 1588 745 — 1750 3441 352 489
Zn(L1)2·2H2O 1585 748 — — 3440 348 492
HL2 1597 — 2703 — — — —
Co(L2)(OAc)·3H2O 1585 733 — 1738 3294 344 485
Co(L2)2·2H2O 1586 741 — — 3310 338 488
Ni(L2)(OAc) ·3H2O 1585 771 — 1744 3280 338 489
Ni(L2)2·2H2O 1587 755 — — 3287 335 492
Cu(L2)(OAc)·H2O 1585 733 — 1746 3400 343 503
Cu(L2)2 1586 733 — — — 348 503
Zn(L2)(OAc)·3H2O 1589 748 — 1740 3318 347 500
Zn(L2)2·2H2O 1589 771 — — 3310 349 497
Table 2: 1H NMR spectral data of Schiﬀ bases and their metal complexes.
Compounds 1HN M R( C D C l 3/DMSO-d6) (ppm)
HL1 [C10H8Cl2N4S] 2.49 (s, 3H, –CH3), 7.35 (dd, 1H, Ar–H), 7.52 (d, 1H, Ar H), 8.08 (d, 1H, ArH), 10.40 (s, 1H, –N=CH–),
11.10 (s, 1H, –SH)
Zn(L1)OAc·3H2O
[C12H16Cl2N4O5SZn]
2.37 (s, 3H, –CH3), 7.41 (dd, 1H, Ar–H), 7.79 (d, 1H, Ar–H), 8.12 (d, 1H, Ar–H), 10.52 (s, 1H, –N=CH–),
2.29 (s, 3H, CH3COO)
Zn(L1)2·2H2O
[C20H18Cl4N8O2S2Zn] 2.58 (s, 3H, –CH3), 7.47 (dd, 1H, Ar–H), 7.78 (d, 1H, Ar–H), 8.08 (d, 1H, Ar–H), 10.58(s, 1H, –N=CH–)
HL2 [C11H10Cl2N4S] 2.84 (q, 2H, –CH2CH3), 1.35 (t, 3H, –CH2CH3), 7.35 (dd, 1H, Ar–H), 7.52 (d, 1H, Ar–H), 8.07 (d, 1H,
Ar–H), 10.55 (s, 1H, –N=CH–), 11.09 (s, 1H, –SH)
Zn(L2)OAc·3H2O
[C13H18Cl2N4O5SZn]
2.67 (q, 2H, –CH2CH3), 1.22 (t, 3H, –CH2CH3), 7.43 (dd, 1H, Ar–H), 7.82 (d, 1H, Ar–H), 8.13 (d, 1H, Ar
H), 10.61 (s, 1H, –N=CH–), 2.32 (s, 3H, CH3COO)
Zn(L2)2·2H2O
[C22H22Cl4N8O2S2Zn]
2.66 (q, 2H, –CH2CH3), 1.18 (t, 3H, –CH2CH3), 7.55 (dd, 1H, Ar–H), 7.83 (d, 1H, Ar–H), 8.13 (d, 1H, Ar
H), 10.60 (s, 1H, –N=CH–)
Table 3: Electronic spectral data of metal complexes.
Compound
Transitions (cm−1)
Dq cm−1 Bc m −1 ν2/ν1 ββ %
ν1 ν2 ν3
Co(L1)(OAc)·3H2O 10897 23031∗ 20998 1213.4 755.9 2.11 0.778 22.2
Co(L1)2·2H2O 10885 22884∗ 20993 1199.9 748.1 2.10 0.770 23.0
Ni(L1)(OAc)·3H2O 10117 17201 24932 1011.7 785.4 1.70 0.754 24.5
Ni(L1)2·2H2O 10123 17320 24950 1012.3 793.4 1.71 0.762 23.7
Co(L2)(OAc)·3H2O 10923 23017∗ 20010 1209.4 683.9 2.09 0.704 29.6
Co(L2)2·2H2O 10935 23041∗ 20016 1210.6 683.5 2.10 0.703 29.6
Ni(L2)(OAc)·3H2O 9999 16380 24885 999.9 751.2 1.63 0.721 27.9
Ni(L2)2·2H2O 9957 16397 24889 995.7 761.0 1.64 0.731 26.9
∗Calculated value.6 Bioinorganic Chemistry and Applications
Table 4: Thermoanalytical results (TG) of the metal complexes.
Compound Steps Temp. (◦C)
TG mass% Assignments
Calcd. Found
Cu(L2)2
1st
2nd
3rd
80–305
305–505
505–695
47.90
21.26
21.26
11.98
45.29
20.27
20.05
15.16
−C14H8Cl4 (organic moiety)
−C4H5N4S (triazole ring)
−C4H5N4S (triazole ring)
−CuO (residue)
Zn(L1)2·2H2O
1st
2nd
3rd
80–230
230–560
560–700
5.37
51.30
33.73
11.90
4.98
51.50
31.12
12.40
−H4O2 (two water molecule)
−C14H8Cl4N2 (organic moiety)
−C6H6N6S2 (triazole ring)
−ZnO (residue)
3.4. Thermal Studies. Thermogravimetric analysis was car-
ried out for Cu(L2)2 and Zn(L1)2·2H2O( Figure 2)f r o m
80◦C to 700◦Ci na t m o s p h e r i ca i r[ 22, 23, 25]. The decom-
position temperature, pyrolysed products, percentage mass
loss of the complexes, and the ash (percent) are given in
Table 4. The thermograms for both of these complexes show
three decomposition steps. In case of Cu(L2)2 complex, the
ﬁrst step 50–305◦C results in a mass loss of 45.29% (calcd.
47.90%)correspondingtoalossorganicmoiety.The2ndand
3rd steps (305–695◦C) correspond to removal of two triazole
molecules with mass loss of 40.32% (calcd. 42.52%) of the
ligand leaving metal oxide as residue.
In case of Zn(L1)2·2H2O complex, the ﬁrst step 50–
230◦C results in a mass loss of 4.98% (calcd. 5.37%)
corresponding to loss of two water molecules. The 2nd steps
corresponds to loss of organic moiety with mass loss 51.50%
(calcd. 51.30%) in the temperature range 230–560◦C. The
3rd step (560–700◦C) corresponds to removal of two triazole
molecules with mass loss of 31.12% (calcd. 33.73%). The
decomposition of both of the complexes ended with oxide
formation.
3.5. ESR Spectra. ESR spectra of 1:1 and 1:2 copper(II)
complexes in solid state at 298K show an intense broad
signal having no hyperﬁne structure. The observed g values
for Cu(L1)(OAc)·H2Oa tr o o mt e m p e r a t u r ea r eg  = 2.18,
g⊥ = 2.10, gav = 2.12, G = 1.81 and for Cu(L1)2 at room
temperature are g  =2.19, g⊥ = 2.12, gav = 2.14, G = 1.59. The
trending values(g  >g ⊥ >2.00)suggestedthattheunpaired
electron is localized in the dx
2-y2 orbital and corresponds to
square planar geometry of the complexes. The g  < 2.3 value
conﬁrms the covalent character of the metal ligand bond.
The axial symmetry parameter G is less than 4.0, indicates
considerable exchange interaction in the solid complex [32].
3.6.AntimicrobialDiscussion. TheSchiﬀbasesandtheirmet-
al complexes were screened for their antibacterial and anti-
fungal activity. All the tested chemical compounds possessed
variable antibacterial activity against Staphylococcus aureus,
Bacillus subtilis and antifungal activity against Aspergillus
niger and Aspergillus ﬂavus. However the compounds in this
series were not eﬀective against any Gram-negative bacteria
(E. coli and P. aeruginosa). Positive controls produced
signiﬁcantly sized inhibition zones against the tested bacteria
andfungi;however,negativecontrolproducednoobservable
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Figure 2: Thermal analyses curve of Zn(L1)2·2H2Oa n dC u ( L 2)2.
inhibitory eﬀect against any of the test organism as shown in
Tables 5, 6,a n d7.
The tested chemical compounds showed zone of inhi-
bition ranging between 15 and 26mm against the Gram
positive bacteria. On the basis of zone of inhibition
produced against the test bacterium, Co(L1)(OAc)·3H2O
and Zn(L1)(OAc)·3H2O were found to be most eﬀec-
tive against S. aureus with zone of inhibition ranging
between 23.6mm and 20.6mm, respectively, and four
compounds HL1,C o ( L 1)(OAc)·3H2O, Zn(L1)(OAc)·3H2O
and Zn(L2)(OAc)·3H2O were found to be best against
B. subtilis, with zone of inhibition ranging between
21.6mm and 23.6mm (Table 5). In the whole series,
the MIC of chemical compounds (Figure 3)r a n g e db e -
tween 16 and 256μg/mL against Gram positive bacteria.
Compound Co(L1)(OAc)·3H2O, Zn(L1)(OAc)·3H2Oa n d
Zn(L2)(OAc)·3H2O were found to be best, as they exhibit
the lowest MIC of 32μg/mL against S. aureus and 16μg/mL
against B. subtilis (Table 6).
All the synthesized compounds screened for their
antifungal activity, among these three compounds HL1,
Co(L1)(OAc)·3H2O, and Co(L1)2·2H2O showed more than
55% inhibition of mycelial growth against Aspergillus niger,
whereas three compounds HL1,C o ( L 1)(OAc)·3H2O, andBioinorganic Chemistry and Applications 7
Table 5: Antibacterial activity of synthesized compounds.
Compound
Diameter of growth of inhibition zone
(mm)a
Staphylococcus aureus Bacillus subtilis
HL1 19.0 21.3
Co(L1)(OAc)·3H2O 23.6 25.6
Co(L1)2·2H2O 16.6 19.6
Ni(L1)(OAc)·3H2O 16.3 18.3
Ni(L1)2·2H2O 14.6 19.6
Cu(L1)(OAc)·H2O 20.3 18.3
Cu(L1)2 15.6 17.0
Zn(L1)(OAc)·3H2O 20.6 23.6
Zn(L1)2·2H2O 19.3 20.6
HL2 17.3 18.3
Co(L2)(OAc)·3H2O 16.6 19.3
Co(L2)2·2H2O 17.6 20.6
Ni(L2)(OAc)·3H2O 15.6 18.3
Ni(L2)2·2H2O 15.0 16.6
Cu(L2)(OAc)·H2O 16.3 18.5
Cu(L2)2 19.6 21.2
Zn(L2)(OAc)·3H2O 20.3 21.6
Zn(L2)2·2H2O 18.3 19.6
Ciproﬂoxacin 26.6 24.0
aValues,includingdiameterofthewell(8mm),aremeansofthreereplicates.
Table 6: Minimum inhibitory concentration (MIC) (in μg/mL) of
compounds.
Sr.
No. Compound Staphylococcus aureus Bacillus subtilis
1H L 1 64 32
2C o ( L 1)(OAc)·3H2O3 2 16
3C o ( L 1)2·2H2O6 4 64
4 Ni(L1)(OAc)·3H2O 128 64
5 Ni(L1)2·2H2O 128 256
6 Cu(L1)(OAc)·H2O6 4 128
7 Cu(L1)2 128 64
8 Zn(L1)(OAc)·3H2O3 2 16
9 Zn(L1)2·2H2O 128 32
10 HL2 128 32
11 Co(L2)(OAc)·3H2O6 4 128
12 Co(L2)2·2H2O 128 32
13 Ni(L2)(OAc)·3H2O 256 128
14 Ni(L2)2·2H2O 128 64
15 Cu(L2)(OAc)·H2O 256 128
16 Cu(L2)2 128 32
17 Zn(L2)(OAc)·3H2O3 2 16
18 Zn(L2)2·2H2O6 4 32
19 Ciproﬂoxacin 5 5
Table 7: Antifungal activity of synthesized compounds.
Compound
Mycelial growth inhibition (%)
Aspergillus niger Aspergillus ﬂavus
HL1 57.7 58.8
Co(L1)(OAc)·3H2O 58.8 61.1
Co(L1)2·2H2O 56.6 55.5
Ni(L1)(OAc)·3H2O 53.3 55.5
Ni(L1)2·2H2O 51.1 47.7
Cu(L1)(OAc)·H2O 50.0 48.8
Cu(L1)2 53.3 52.5
Zn(L1)(OAc)·3H2O 54.4 56.6
Zn(L1)2·2H2O 51.1 50.0
HL2 48.8 45.5
Co(L2)(OAc)·3H2O 46.6 47.7
Co(L2)2·2H2O 48.8 50.0
Ni(L2)(OAc)·3H2O 44.4 45.5
Ni(L2)2·2H2O 45.5 43.3
Cu(L2)(OAc)·H2O 48.8 50.0
Cu(L2)2 52.5 54.4
Zn(L2)(OAc)·3H2O 53.3 52.5
Zn(L2)2·2H2O 50.0 51.1
Fluconazole 81.1 77.7
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Figure 3: Comparison of minimum inhibitory concentration of
compounds with Ciproﬂoxacin.
Zn(L1)(OAc)·3H2O, showed more than 55% inhibition
of mycelial growth against A. ﬂavus. Co(L1)(OAc)·3H2O
showed the highest inhibition of fungal mycelium (61%)
against A. ﬂavus (Table 7). Among all the tested chemical
compounds, Co(L1)(OAc)·3H2O showed highest antibac-
terial and antifungal activity. The antimicrobial studies
suggested that the Schiﬀ bases were found to be biologi-
cally active and their metal complexes showed signiﬁcantly8 Bioinorganic Chemistry and Applications
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Figure 4: Structures of metal complexes.
enhancedantibacterial and antifungal activity against micro-
bial strains in comparison to the free ligands. The overtone’s
concept [33] and Tweedy’s chelation theory [34]c a nb e
used to explain the enhanced in antimicrobial activity of
the metal complexes. According to the Overtone’s concept of
cell permeability, the lipid membrane surrounding the cell
favors the passage of only lipid-soluble materials; therefore,
liposolubility is an important factor which controls the
antimicrobial activity. On chelation, polarity of the metal
ion is reduced to a greater extent due the overlapping of the
ligand orbital and partial sharing of the positive charge of
the metal ion with donor groups. Moreover, delocalization
of the π-electrons over the whole chelate ring is increased
andlipophilicityofthecomplexesisenhanced.Theincreased
lipophilicity enhances the penetration of the complexes into
thelipidmembranesandblocksthemetalbindingsitesinthe
enzymes of microorganisms. These complexes also disturb
therespirationprocessofthecellandthusblockthesynthesis
of proteins, which restricts further growth of the organism.
In general, metal complexes are more active than ligands as
they may serve as principal cytotoxic species.
4. Conclusion
The Schiﬀ bases HL1 and HL2 coordinate in 1:1 and 1:2
metal-ligand ratios, as conﬁrmed by analytical, IR, PMR,
electronic, magnetic measurements, and thermal studies.
The presence of coordinated water in metal complexes was
conﬁrmed by IR and TG studies. The trend in g values
(g  >g ⊥ > 2.00) suggested that the unpaired elec-
tron is localized in the dx
2-y2 orbital and corresponds to
square planar geometry of the copper complexes. Based on
these, the proposed structures are shown in Figure 4.T h e
antimicrobial studies suggested that the Schiﬀ bases were
found to be biologically active, and their metal complexes
showed signiﬁcantly enhanced antibacterial and antifungal
activity against microbial strains in comparison to the free
ligands. Thus, exhibiting their broad spectrum nature can
be further used in pharmaceutical industry for mankind, as
an antimicrobial agent, after testing its toxicity to human
beings.
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